Japanese encephalitis vaccine in travelers.

Full Abstract

Extensive vaccination against Japanese encephalitis (JE) has been carried out in many Asian countries for the past 20 years and is also increasingly recommended for travelers to endemic areas. Concerns have been raised regarding potential neurological and allergic side effects of the currently available JE vaccine, which is manufactured from mouse brain. A new purified, inactivated JE virus vaccine (IC51) has been developed, which is manufactured in a Vero cell culture substrate. Studies show that the vaccine is both safe and immunogenic and the product will be licensed very soon for use in many industrialized countries. Once a highly immunogenic and safe product is available, wider use of JE vaccine in travelers will be prudent. Currently, vaccination is restricted to travelers with an increased risk of acquiring JE. Individuals at increased risk have been defined quite arbitrarily as travelers with increased behavioral contact to JE-transmitting mosquitoes, in particular, during stays in rural areas and during the transmission season. However, the possibility of an infection with JE virus can never be ruled out when traveling to endemic areas and infection can prove disastrous for the individual concerned. Since a safe product will be available very soon, guidelines and recommendations will have to be reconsidered.

Learn Faster Today Improve your study skills

Author information

Author/s: Jelinek, Tomas (T);

Affiliation: Berlin Center for Travel & Tropical Medicine, Jägerstrasse 67-69, 10117 Berlin, Germany. jelinek(-atsign-)bctropen.de

Journal and publication information

Publication Type: Journal Article

Journal: Expert review of vaccines (Expert Rev Vaccines), published in England. (Language: eng)

Reference: 2008-Jul; vol 7 (issue 5) : pp 689-93

Dates: Created 2008/06/19; Completed 2008/08/15;

PMID: 18564023, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Animals
Cercopithecus aethiops
Encephalitis, Japanese - immunology; prevention & control
Humans
Japanese Encephalitis Vaccines - adverse effects; pharmacology; therapeutic use

Mice
Travel
Vaccination - utilization
Vaccines, Inactivated - pharmacology
Vero Cells

Associated Chemicals: Japanese Encephalitis Vaccines (0) ; Vaccines, Inactivated (0)

These are the highest related articles currently in the database:

Yellow fever and Japanese encephalitis vaccines: indications and complications. 27 Feb 2005
Japanese encephalitis in a U.S. traveler returning from Thailand, 2004. 9 Feb 2005
Japanese encephalitis for a reference to international travelers. 29 Jun 2007
Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand. 14 Jun 2008
Simultaneous vaccination in Japanese travelers. 26 Sep 2006
[Tissue culture inactivated vaccine for the prevention of Japanese encephalitis: experimental and laboratory process and control layout] 29 Apr 2007
Dengue vaccines for travelers. 29 Jun 2008
[Japanese encephalitis vaccine] 29 Apr 2005
Japanese encephalitis: the need for a more effective vaccine. 29 Sep 2005

See 100+ related articles.